See All Slides - tctmd.com

Slides

Presentation TCT 2012

A New Device for Intracoronary Infusion

Presenter: Nabil Dib

October 22, 2012

Presentation TCT 2012

TCT-114: Feasibility of Noninvasive Atherectomy: Plaque Ablation with Cavitation-Based Focused Ultrasound (Histotripsy)

Presenter: Adam Maxwell

October 22, 2012

Presentation TCT 2012

Case Presentation with Discussion(9)

Presenter: Rogerio Sarmento-Leite

October 22, 2012

Presentation TCT 2012

A Detailed Analysis of Stent Thrombosis from the SYNTAX Trial (All Patients and Left Main vs. Multivessel Disease Cohorts): Frequency, Timing, Vessel, and Contribution to...

Presenter: Patrick Serruys

October 22, 2012

Presentation TCT 2012

P2Y12 Inhibitors: Specific Agents for Specific Patient Cohorts? (STEMI, Diabetes, CKD, Prior Stroke, Etc.)

Presenter: Dirk Sibbing

October 22, 2012

Presentation TCT 2012

DES Clinical Outcomes Meta-analysis

Presenter: Sripal Bangalore

October 22, 2012

Presentation TCT 2012

US Perspectives(3)

Presenter: Gregg Stone

October 22, 2012

$PADN-1: Pulmonary Artery Denervation for the Treatment of Refractory Pulmonary Hypertension$

Presentation TCT 2012

PADN-1: Pulmonary Artery Denervation for the Treatment of Refractory Pulmonary Hypertension

Presenter: Shao Liang Chen

October 22, 2012

Presentation TCT 2012

When Do I Prefer Transcarotid Alternative Access for TAVR?

Presenter: Vasilis Babaliaros

October 22, 2012

Presentation TCT 2012

PARIS 1-Year: Impact of DAPT Cessation and Non-adherence on Adverse Events Following PCI

Presenter: Roxana Mehran

October 22, 2012

Advertisement

Slides

A New Device for Intracoronary Infusion

TCT-114: Feasibility of Noninvasive Atherectomy: Plaque Ablation with Cavitation-Based Focused Ultrasound (Histotripsy)

Case Presentation with Discussion(9)

A Detailed Analysis of Stent Thrombosis from the SYNTAX Trial (All Patients and Left Main vs. Multivessel Disease Cohorts): Frequency, Timing, Vessel, and Contribution to...

P2Y12 Inhibitors: Specific Agents for Specific Patient Cohorts? (STEMI, Diabetes, CKD, Prior Stroke, Etc.)

DES Clinical Outcomes Meta-analysis

US Perspectives(3)

PADN-1: Pulmonary Artery Denervation for the Treatment of Refractory Pulmonary Hypertension

When Do I Prefer Transcarotid Alternative Access for TAVR?

PARIS 1-Year: Impact of DAPT Cessation and Non-adherence on Adverse Events Following PCI

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content